PDF) WTX101 in patients newly diagnosed with Wilson disease: final

PDF) Wilson's Disease: An Update on the Diagnostic Workup and Management

PDF) Edging closer to successful gene therapy for Wilson disease

Table 4 from EASL Clinical Practice Guidelines: Wilson's disease.

PDF) Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease - Paternostro - 2020 - Liver International - Wiley Online Library

Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease

History of Wilson Disease - ScienceDirect

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

Characteristics and outcomes of hospitalized patients with Wilson's disease in the United States: A national survey

PDF) Diagnosis and management of Wilson's disease: Current perspectives

Update on the Diagnosis and Management of Wilson Disease

Cureus, Demographics and Outcomes Related to Wilson's Disease Patients: A Nationwide Inpatient Cohort Study

PDF) The Present and Future Challenges of Wilson's Disease Diagnosis and Treatment

PDF) Advances in Treatment of Wilson Disease

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect